Tuesday, August 2, 2016

RIGL Awaits Key Data This Month, GeoVax Gets Funding, ADXS Jumps On Amgen Deal

Shares of Advaxis Inc. (ADXS) jumped over 30% on Tuesday, following a $540 million global cancer immunotherapies collaboration with Amgen (AMGN).

from RTT - Biotech http://ift.tt/2atv04A
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)